These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36219050)

  • 1. A Survey of Patient Attitudes Towards Topical Minoxidil in the Treatment of Hair Loss.
    Nussbaum D; Murphy E; Nelson K; Gonzalez-Lopez A; Qureshi A; Schwartz J; Friedman A
    J Drugs Dermatol; 2022 Oct; 21(10):1140-1142. PubMed ID: 36219050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar response patterns to topical minoxidil foam 5% in frontal and vertex scalp of men with androgenetic alopecia: a microarray analysis.
    Mirmirani P; Consolo M; Oyetakin-White P; Baron E; Leahy P; Karnik P
    Br J Dermatol; 2015 Jun; 172(6):1555-1561. PubMed ID: 25204361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgenetic alopecia.
    Piraccini BM; Alessandrini A
    G Ital Dermatol Venereol; 2014 Feb; 149(1):15-24. PubMed ID: 24566563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: Clinical, histopathological, and physicochemical study.
    Abdel-Raouf H; Aly UF; Medhat W; Ahmed SS; Abdel-Aziz RTA
    Dermatol Ther; 2021 Jan; 34(1):e14678. PubMed ID: 33320406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of androgenetic alopecia.
    Tosti A; Camacho-Martinez F; Dawber R
    J Eur Acad Dermatol Venereol; 1999 May; 12(3):205-14. PubMed ID: 10461639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
    J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgenetic alopecia in women.
    Price VH
    J Investig Dermatol Symp Proc; 2003 Jun; 8(1):24-7. PubMed ID: 12894991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia.
    Stamatas GN; Wu J; Pappas A; Mirmirani P; McCormick TS; Cooper KD; Consolo M; Schastnaya J; Ozerov IV; Aliper A; Zhavoronkov A
    Cell Cycle; 2017; 16(17):1578-1584. PubMed ID: 28594262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Split-scalp pilot study to evaluate effectiveness of Minoxidil 0,5% MMP® versus Topical Minoxidil 5% in the treatment of Female Pattern Hair Loss.
    Corrêa AC; Machado CJ; Carneiro SCS
    Arch Dermatol Res; 2024 Jun; 316(6):313. PubMed ID: 38822940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
    Suchonwanit P; Rojhirunsakool S; Khunkhet S
    Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical 5% minoxidil versus combined erbium YAG laser and topical 5% minoxidil in androgenetic alopecia: A randomized controlled trial.
    Mokhtari F; Zavare Z; Iraji F
    J Cosmet Dermatol; 2023 Oct; 22(10):2737-2743. PubMed ID: 37574862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel enzymatic assay predicts minoxidil response in the treatment of androgenetic alopecia.
    Goren A; Castano JA; McCoy J; Bermudez F; Lotti T
    Dermatol Ther; 2014; 27(3):171-3. PubMed ID: 24283387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug treatment of alopecia].
    Wolff H
    Internist (Berl); 2015 Oct; 56(10):1196-208. PubMed ID: 26383761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgenetic alopecia: an evidence-based treatment update.
    Varothai S; Bergfeld WF
    Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the treatment of male pattern hair loss.
    York K; Meah N; Bhoyrul B; Sinclair R
    Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
    [No Abstract]   [Full Text] [Related]  

  • 16. The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review.
    Sung CT; Juhasz ML; Choi FD; Mesinkovska NA
    J Drugs Dermatol; 2019 Feb; 18(2):155-160. PubMed ID: 30794366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men.
    Hillmann K; Garcia Bartels N; Kottner J; Stroux A; Canfield D; Blume-Peytavi U
    Skin Pharmacol Physiol; 2015; 28(5):236-44. PubMed ID: 25765348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
    Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
    J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
    Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
    Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.